Page last updated: 2024-11-08

pretyrosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pretyrosine: RN given refers to (1(S)-cis)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-arogenate(1-) : Conjugate base of L-arogenic acid arising from deprotonation of the two carboxy groups and protonation of the amino group; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25244469
CHEBI ID58180
MeSH IDM0064760

Synonyms (7)

Synonym
l-arogenate
pretyrosine
l-arogenate anion
1-[(2s)-2-azaniumyl-2-carboxylatoethyl]-4-hydroxycyclohexa-2,5-diene-1-carboxylate
l-arogenate(1-)
CHEBI:58180
Q27125430
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dicarboxylic acid anion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
superpathway of phenylalanine, tyrosine and tryptophan biosynthesis2925
L-tyrosine biosynthesis III09
L-phenylalanine biosynthesis II1014
L-tyrosine biosynthesis II610
superpathway of L-phenylalanine and L-tyrosine biosynthesis1213
L-tyrosine biosynthesis II611
L-tyrosine biosynthesis III19
L-phenylalanine biosynthesis II314
superpathway of L-phenylalanine and L-tyrosine biosynthesis516
tyrosine biosynthesis III29

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (48.39)18.7374
1990's2 (6.45)18.2507
2000's4 (12.90)29.6817
2010's8 (25.81)24.3611
2020's2 (6.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]